Drug major Sun Pharmaceutical Industries today said the company, along with its subsidiary, has received abbreviated new drug application (ANDA) approval for four generic products from the US health regulator.

Also Read   News Now Paper Specials - Sensex makes remarkable recovery, regains 17K - Range-trading may continue this week - US sleuths believe ISI had links with Headley - India not worried about US honouring n-deal: PM - Vendata expects quick nod for Orissa project More     Also Read   News Now Paper Specials - Bank rates go down in spite of RBI signal - IAF orders more Tejas LCAs to replace MiG-21s - Obama-Singh to run last mile on nuclear deal - RIL may fuel India Inc's overseas M&A drive - Medicis takes Lupin to US court on patent charge - Suzlon shifts global HQ ops back to India More   Also Read   News Now Paper Specials   - Q3 FY09 Results: Earnings Season - Saving Satyam: Govt gets into action - India-Pakistan Tensions: Fallout of Mumbai Terror Attack - Your Money: Where to invest - Market Crash: Global worries weigh - Time Out: Books, fashion, food, travel, sports, health...  More

The company has received approvals from the US Food and Drug Administrator (USFDA) for generic hydrocodone bitarlate with acetaminophen (APAP) tablets, generic Aredia Pamidronate Disodium injections, generic Lopid gemfibrozil tablets and generic Phenargan promethazine hydrochloride tablets in various strengths, Sun Pharma said in a statement.

These products -- both generic and branded verions -- all together have annualised sales of more than $650 million in the US.

The company has received the approval for 10 generic versions of Hydrocodone with APAP used as pain reliever for acute, chronic and post operative pains, it added.

While Lopid tablets are used as cholesterol reducing agents and generic Aredia injections can treat hypercalcemia, Phenargan tablets are pain relievers, the company said.

All these products are manufactured at multiple facilities of the company and its subsidiaries in the US and India.

Other Stories      - Sensex makes remarkable recovery, regains 17K - L N Mittal doubles his stake in Ophir Energy - Indian handicraft firms to participate in Munich fair - Microsoft eyes Indian smartphone mkt - RIL Hazira unit bags 'Excellent Energy Efficient Unit Award' More

Read Business news in  Advertisements   Get financial advisory and solutions for your projects   Holidays starting at a delightful EMI of Rs 3481   Switch on and say hello to Monday morning !   Your dream home can now be a reality.   Visit Fortis for a preventive health check-up & get a 20% discount.   Follow the ups and downs of your investments. Try our new Portfolio Tracker   Kolkata Dock \ Freight contract for the British Gurkhas Nepal   Find how Midsize Businesses use ERP to gain competitive advantage   Trading in Forex is now as easy as 1-2-3   Discover an economical and cost effective way to market your products and services   Giftwithlove.com: Same day delivery of Flowers and Cakes to India   Download the E-book on the Future of Business Intelligence   Learn Best Practices for improving customer satisfaction   Know your customers better... download the free e-book on CRM